ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 730009 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 730009; 2) Community: the network communities that were significantly associated with the response to NSC 730009; 3) Molecule: the relationships between components within communities and NSC 730009; 4) MDR: the compounds that were significantly associated with the NSC 730009.

NSC Compound Enrichment Correlation
NSC 727621 11-(4'-Aminobutylidene)-5,6-dihydro-5-oxo-2,3-dimethoxy-6-me thyl-8,9-methylenedioxy-11H-indeno[1,2-c]isoquinoline 0.0130238833303634 0.40905408
NSC 728032 6'-Amino-2'-thioxo-1',2',3,3'-tetrahydro-1H-spiro[benzimidaz ole-2,4'-pyrimidine]-5'-carbonitrile 0.0130238833303634 0.24859904
NSC 728091 6-[(3-Hydroxy)-1-propyl]-5,6-dihydro-2,3-dimethoxy-8,9-methy lenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.0130238833303634 0.5333644
NSC 735037 Camptothecin Derivative 0.0130238833303634 0.65360384
NSC 745929 Null 0.0130238833303634 -0.049657516
NSC 75520 Thymidine, .alpha.,.alpha.,.alpha.-trifluoro- (8CI 9CI) 0.0130238833303634 0.61940933
NSC 77039 Null 0.0130238833303634 0.49580466
NSC 269599 Stannane, chlorohydroxydiphenyl- 0.0135714101922724 0.044657007
NSC 363812 Tetraplatin 0.0135714101922724 0.52225986
NSC 39135 Null 0.0135714101922724 0.10096618
Total:90  Current:36    [First] [Prev] [Next] [Last]